KB Financial : Update on Kookmin Bank's Decision on Capital Injection in PT Bank KB Bukopin Tbk - Form 6-K

Update on Kookmin Bank's Decision on Capital Injection in PT Bank KB Bukopin Tbk.

On February 16, 2023, KB Financial Group Inc. ("KB Financial Group") updated its previous disclosure made on October 11, 2022 regarding the decision by Kookmin Bank, one of KB Financial Group's wholly-owned subsidiaries, to inject capital into PT Bank KB Bukopin Tbk. ("Bank KB Bukopin"), as follows:

On February 16, 2023, the board of directors of Kookmin Bank passed a new resolution revising the maximum amount of capital injection to be made by Kookmin Bank into Bank Bukopin. Pursuant to this new resolution, if Bank KB Bukopin decides to increase its capital by issuing new shares in pursuit of its swift business normalization and procurement of future growth drivers, then Kookmin Bank would participate in such rights offering by Bank KB Bukopin within the maximum amount of IDR 12,000 billion (equivalent to approximately KRW 1 trillion) (the "Capital Injection"), an increase from IDR 8,436 billion, the originally planned amount of capital injection previously disclosed on KB Financial Group's Form 6-K furnished on October 11, 2022. The original amount was computed based on, among others, Kookmin Bank's ownership in Bank KB Bukopin, while the revised amount also reflects Kookmin Bank's most conservative considerations of several factors relating to the Capital Injection, including the conditions of the Indonesian financial market.

*	Note: Such amount in KRW is subject to change based on exchange rates.

Currently, however, details of neither Bank KB Bukopin's rights offering (including the number of shares to be issued and the issue price) nor the Capital Injection (including the number of shares to be acquired, the purchase price and the total number of shares to be owned by Kookmin Bank following the Capital Injection) still have been determined, and as such, KB Financial Group plans to make further disclosures at which point such matters have been determined. In addition, the expected date of the acquisition of Bank KB Bukopin's new shares is subject to further discussions with the financial authorities.

The key details of the Capital Injection remain the same as previously disclosed on KB Financial Group's Form 6-K furnished on October 11, 2022, except for Item 1.B and Item 4, as shown below:

1.	Information on Bank KB Bukopin as of September 30, 2022:

A.

Total number of shares issued: 67,887,540,178 shares

B.

Share Capital: KRW 588,700,000,000 (converted from IDR to KRW at the exchange rate announced on February 16, 2023 (IDR 1.00 = KRW 0.0841))

C.

Primary areas of business: Banking

2.	Method of the Capital Injection: Cash payment for the acquisition of new shares

3.	Purpose of the Capital Injection: Participate in the rights offering by Bank KB Bukopin in pursuit of its business normalization and procurement of future growth drivers

4.	Key Financial Information of Bank KB Bukopin:

			(Unit: millions of KRW)
Period		Total Assets			Total Liabilities			Total Equity			Share Capital			Operating Revenue			Net Income
FY2021			7,503,038				6,392,422				1,110,617				588,700				354,701				-193,622
FY2020			6,722,834				6,010,807				712,028				292,548				446,434				-274,007
FY2019			8,432,223				7,683,272				748,951				115,758				653,025				18,229

*	Note: The figures above have been converted from IDR to KRW at the exchange rate announced on February 16, 2023 (IDR 1.00 = KRW 0.0841).

For a comparison of this updated disclosure and the previous disclosure regarding Kookmin Bank's Decision on Capital Injection in Bank KB Bukopin, please refer to the Form 6-K titled "Kookmin Bank's Decision on Capital Injection in PT Bank KB Bukopin Tbk" previously furnished by KB Financial Group on October 11, 2022.